In this episode, we chatted with Melanie Ivarsson, Chief Development Officer at Moderna, who led teams in times the world was anxiously waiting for them to deliver us a hope with Covid Vaccine… and they did. How did they achieve this? How do you lead in such unprecedented times? How do you ensure this sense of purpose continues to live today? Hear all about those stories and about Melanie’s biggest leadership learning throughout this once-in-a-lifetime experience: Enable others to be the best they can be, and don’t get in their way.
“Hang on to your true self.”
MEET OUR GUEST Melanie Ivarsson Chief Development Officer at Moderna.
Melanie Ivarsson is Senior Vice President, Chief Development Officer at Moderna, where she leads the Clinical Development Operations department. In this role Dr Ivarsson and her team deliver all clinical programs within the Moderna portfolio.
Melanie has more than 20 years of experience in the pharmaceutical industry. Prior to joining Moderna, she was Head of Global Clinical Operations, at Takeda (following the acquisition of Shire) and spent 9 years at Pfizer in Clinical Development. She also held roles within the early clinical development group at Eli Lilly.
After receiving her PhD from the University of Bristol, she completed postdoctoral research at Lund University and New York University. Dr Ivarsson also holds an Executive MBA from MIT Sloan School of Management.
Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host today, having the pleasure to be joined by Melanie Ivarsson Chief Development Officer at Moderna. In this role Melanie leads the Clinical Development Operations department and delivers with her team all clinical programs within the Moderna portfolio. Prior to joining Moderna, she was Head of Global Clinical Operations at Takeda and spent 9 years at Pfizer in…